1. Home
  2. PRGO vs VCEL Comparison

PRGO vs VCEL Comparison

Compare PRGO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$13.25

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

BUY

Current Price

$37.01

Market Cap

2.0B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
PRGO
VCEL
Founded
1887
1989
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1991
1997

Fundamental Metrics

Financial Performance
Metric
PRGO
VCEL
Price
$13.25
$37.01
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$22.50
$60.40
AVG Volume (30 Days)
4.1M
573.8K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
8.63%
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
$4,281,800,000.00
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$146.91
Revenue Growth
N/A
14.05
52 Week Low
$12.17
$29.24
52 Week High
$30.93
$63.00

Technical Indicators

Market Signals
Indicator
PRGO
VCEL
Relative Strength Index (RSI) 31.07 46.91
Support Level $13.34 $35.85
Resistance Level $14.12 $42.68
Average True Range (ATR) 0.47 1.77
MACD 0.32 -0.52
Stochastic Oscillator 55.64 18.39

Price Performance

Historical Comparison
PRGO
VCEL

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: